SCHEMBL8259014

SCHEMBL8259014

Nc1ccc(-c2cccc(C(=O)Nc3nc4c(C(=O)Nc5ncc[nH]5)cccc4[nH]3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.43
ADORA2A P29274 3/20 0.43
ADORA2B P29275 1/20 0.43
ADORA1 P30542 1/20 0.43
PARP1 P09874 7/20 0.43
PARP2 Q9UGN5 5/20 0.43
CDK12 Q9NYV4 4/20 0.43
CDK1 P06493 1/20 0.43
CDK2 P24941 1/20 0.43
CDK5 Q00535 1/20 0.43
NPC1 O15118 7/20 0.42
RAB9A P51151 7/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
IRAK4 Q9NWZ3 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
PKM P14618 2/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1201788 0.89 IRAK4 (0.51) MAOBADORA2AADORA2BADORA1PARP1
SCHEMBL1202079 0.87 MAOB (0.53) MAOBADORA2AADORA2BADORA1PARP1
SCHEMBL1201724 0.87 IRAK4 (0.47) MAOBADORA2AADORA2BADORA1PARP1
SCHEMBL1201005 0.86 IRAK4 (0.57) MAOBADORA2AADORA2BADORA1PARP1
SCHEMBL9611644 0.85 MAOB (0.48) MAOBADORA2AADORA2BADORA1PARP1
SCHEMBL1202142 0.84 IRAK4 (0.50) MAOBADORA2AADORA2BADORA1PARP1
SCHEMBL1201877 0.84 PKN1 (0.47) MAOBADORA2AADORA2BADORA1PARP1
SCHEMBL1201653 0.83 PARP1 (0.49) MAOBADORA2AADORA2BADORA1PARP1
SCHEMBL1202155 0.83 MAOB (0.46) MAOBADORA2AADORA2BADORA1PARP1
SCHEMBL1200975 0.83 MAOB (0.45) MAOBADORA2AADORA2BADORA1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006099379-A2 BENZAZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE AS B-SECRETASE INHIBITORS TRANSTECH PHARMA, INC. (US) 2006-09-21 WO disclosed